Smart Money Is Betting Big In LLY Options
Smart Money Is Betting Big In LLY Options
Financial giants have made a conspicuous bearish move on Eli Lilly. Our analysis of options history for Eli Lilly (NYSE:LLY) revealed 21 unusual trades.
金融巨头对礼来采取了明显的看跌举动。我们对礼来（纽约证券交易所代码：LLY）期权历史的分析显示了21笔不寻常的交易。
Delving into the details, we found 28% of traders were bullish, while 52% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $168,350, and 17 were calls, valued at $1,103,918.
深入研究细节，我们发现28％的交易者看涨，而52％的交易者表现出看跌倾向。在我们发现的所有交易中，有4笔是看跌期权，价值为168,350美元，17笔是看涨期权，价值1,103,918美元。
Projected Price Targets
预计价格目标
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $400.0 to $1080.0 for Eli Lilly over the recent three months.
根据交易活动，看来重要投资者的目标是在最近三个月中将礼来的价格区间从400.0美元扩大到1080.0美元。
Insights into Volume & Open Interest
对交易量和未平仓合约的见解
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
查看交易量和未平仓合约是一种对股票进行尽职调查的有见地的方法。
This data can help you track the liquidity and interest for Eli Lilly's options for a given strike price.
这些数据可以帮助您跟踪礼来公司期权在给定行使价下的流动性和利息。
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Eli Lilly's whale activity within a strike price range from $400.0 to $1080.0 in the last 30 days.
下面，我们可以观察到过去30天内礼来公司在行使价范围内所有鲸鱼活动的看涨和看跌期权交易量和未平仓合约的分别变化。
Eli Lilly Option Activity Analysis: Last 30 Days
礼来期权活动分析：过去 30 天
Significant Options Trades Detected:
检测到的重要期权交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | CALL | SWEEP | BEARISH | 12/19/25 | $143.95 | $137.65 | $139.35 | $940.00 | $249.1K | 220 | 17 |
| LLY | CALL | TRADE | NEUTRAL | 01/16/26 | $410.4 | $399.8 | $405.8 | $550.00 | $202.9K | 57 | 0 |
| LLY | CALL | SWEEP | BULLISH | 09/13/24 | $5.0 | $4.65 | $5.0 | $930.00 | $92.5K | 906 | 252 |
| LLY | CALL | TRADE | BULLISH | 11/15/24 | $61.0 | $59.05 | $61.0 | $910.00 | $54.9K | 230 | 15 |
| LLY | PUT | TRADE | NEUTRAL | 09/13/24 | $58.4 | $52.0 | $54.85 | $960.00 | $54.8K | 47 | 0 |
| 符号 | 看跌/看涨 | 交易类型 | 情绪 | Exp。日期 | 问 | 出价 | 价格 | 行使价 | 总交易价格 | 未平仓合约 | 音量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 莉莉 | 打电话 | 扫 | 粗鲁的 | 12/19/25 | 143.95 美元 | 137.65 美元 | 139.35 美元 | 940.00 美元 | 249.1 万美元 | 220 | 17 |
| 莉莉 | 打电话 | 贸易 | 中立 | 01/16/26 | 410.4 美元 | 399.8 美元 | 405.8 美元 | 550.00 美元 | 202.9 万美元 | 57 | 0 |
| 莉莉 | 打电话 | 扫 | 看涨 | 09/13/24 | 5.0 美元 | 4.65 美元 | 5.0 美元 | 930.00 美元 | 92.5 万美元 | 906 | 252 |
| 莉莉 | 打电话 | 贸易 | 看涨 | 11/15/24 | 61.0 美元 | 59.05 美元 | 61.0 美元 | 910.00 美元 | 54.9 万美元 | 230 | 15 |
| 莉莉 | 放 | 贸易 | 中立 | 09/13/24 | 58.4 美元 | 52.0 美元 | 54.85 美元 | 960.00 美元 | 54.8 万美元 | 47 | 0 |
About Eli Lilly
关于 Eli Lilly
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
礼来是一家专注于神经科学、心脏代谢、癌症和免疫学的制药公司。礼来公司的关键产品包括用于癌症的Verzenio；用于心脏代谢的Mounjaro、Zepbound、Jardiance、Trulicity、Humalog和Humulin；以及用于免疫学的Taltz和Olumiant。
In light of the recent options history for Eli Lilly, it's now appropriate to focus on the company itself. We aim to explore its current performance.
鉴于礼来公司最近的期权历史，现在应该专注于公司本身。我们的目标是探索其目前的表现。
Current Position of Eli Lilly
礼来公司目前的职位
- With a trading volume of 330,623, the price of LLY is up by 0.36%, reaching $906.0.
- Current RSI values indicate that the stock is is currently neutral between overbought and oversold.
- Next earnings report is scheduled for 52 days from now.
- LLY的交易量为330,623美元，价格上涨了0.36％，达到906.0美元。
- 当前的RSI值表明，该股目前在超买和超卖之间处于中立状态。
- 下一份收益报告定于即日起52天后发布。
Professional Analyst Ratings for Eli Lilly
礼来公司的专业分析师评级
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $1019.2.
在过去的30天中，共有5位专业分析师对该股发表了看法，将平均目标股价定为1019.2美元。
- Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $885.
- Consistent in their evaluation, an analyst from Guggenheim keeps a Buy rating on Eli Lilly with a target price of $1030.
- An analyst from Berenberg persists with their Buy rating on Eli Lilly, maintaining a target price of $1050.
- In a positive move, an analyst from Deutsche Bank has upgraded their rating to Buy and adjusted the price target to $1025.
- In a cautious move, an analyst from Morgan Stanley downgraded its rating to Overweight, setting a price target of $1106.
- 坎托·菲茨杰拉德的一位分析师将其评级下调至增持，新的目标股价为885美元，这反映了人们的担忧。
- 古根海姆的一位分析师在评估中保持了对礼来公司的买入评级，目标价为1030美元。
- 贝伦贝格的一位分析师坚持对礼来公司的买入评级，将目标价维持在1050美元。
- 德意志银行的一位分析师将其评级上调为买入，并将目标股价调整为1025美元，这是一个积极的举动。
- 摩根士丹利的一位分析师谨慎地将其评级下调至增持，将目标股价定为1106美元。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
与仅交易股票相比，期权是一种风险更高的资产，但它们具有更高的获利潜力。严肃的期权交易者通过每天自我教育、扩大交易规模、关注多个指标以及密切关注市场来管理这种风险。